ClinicalTrials.Veeva

Menu

Diaphragmatic Ultrasound and Thoracic Fluid Content for Prediction of Non-Invasive Ventilation Failure in Neonates

L

Lamiaa Khaled Zidan

Status

Completed

Conditions

RDS of Prematurity
Non Invasive Ventilation (NIV)
Diaphragm Ultrasound
Electrical Cardiometry

Treatments

Device: Diaphragmatic US
Device: EC

Study type

Observational

Funder types

Other

Identifiers

NCT07148102
DTF, DE, TFC with NIV failure

Details and patient eligibility

About

This research assessed diaphragmatic ultrasound and thoracic fluid content (TFC) as potential early predictive tools for detecting NIV failure in preterm neonates.

Full description

Non-invasive ventilatory support (NIV) is considered a gold standard care for preterm infants with respiratory distress syndrome (RDS); however, NIV failure remains a frequent challenge that is often associated with many adverse outcomes

Enrollment

90 patients

Sex

All

Ages

30 to 30 minutes old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Preterm neonates of both sexes, with gestational ages ranging from 28 to 34 weeks, diagnosed with RDS and requiring non-invasive ventilation within 30 minutes of birth

Exclusion criteria

  • Exclusion criteria included intubation in the delivery room, complex congenital heart disease, major congenital anomalies in the lungs or airways, and other causes of respiratory distress unrelated to RDS.

Trial design

90 participants in 3 patient groups

CPAP
Description:
30 infants supported by nasal CPAP
Treatment:
Device: EC
Device: Diaphragmatic US
NIPPV
Description:
30 infants supported by non-invasive positive pressure ventilation
Treatment:
Device: EC
Device: Diaphragmatic US
NHFOV
Description:
30 infants supported with nasal high-frequency oscillatory ventilation
Treatment:
Device: EC
Device: Diaphragmatic US

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems